Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.

Details

Ressource 1Download: 36298797_BIB_2AE29CC09CEA.pdf (1512.93 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_2AE29CC09CEA
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
Journal
Viruses
Author(s)
Walser M., Mayor J., Rothenberger S.
ISSN
1999-4915 (Electronic)
ISSN-L
1999-4915
Publication state
Published
Issued date
12/10/2022
Peer-reviewed
Oui
Volume
14
Number
10
Pages
2242
Language
english
Notes
Publication types: Journal Article ; Review ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Abstract
Designed ankyrin repeat proteins (DARPins) are engineered proteins comprising consensus designed ankyrin repeats as scaffold. Tightly packed repeats form a continuous hydrophobic core and a large groove-like solvent-accessible surface that creates a binding surface. DARPin domains recognizing a target of interest with high specificity and affinity can be generated using a synthetic combinatorial library and in vitro selection methods. They can be linked together in a single molecule to build multispecific and multifunctional proteins without affecting expression or function. The modular architecture of DARPins offers unprecedented possibilities of design and opens avenues for innovative antiviral strategies.
Keywords
Designed Ankyrin Repeat Proteins, Virus Internalization, Ankyrin Repeat, Proteins, HIV Fusion Inhibitors, Solvents, COVID-19, DARPin, SARS-CoV-2, ankyrin repeat protein, antiviral therapy, emerging virus, multispecificity, protein design, protein scaffold
Pubmed
Web of science
Open Access
Yes
Create date
08/11/2022 12:02
Last modification date
23/01/2024 7:22
Usage data